Addiction Medicine

Even light smokers need to quit, and a new study shows what can help them

Published in Pain and Central Nervous System Week, April 25th, 2005

Current research provides new hope for smokers who may think medicinal nicotine can't help them quit.

Researchers examined data from a previous trial involving 917 smokers randomized to a placebo or to the 2 mg Commit lozenge marketed by GlaxoSmithKline (GSK) Consumer Healthcare. They found that 2 mg Commit can significantly increase light smokers' chances of quitting successfully. The analysis is the first of its kind that focuses specifically on light smokers, defined as people who smoke 15 cigarettes per day or less, and who smoke their first cigarette of the day more than 30 minutes after waking, an indicator of low tobacco dependence.

The...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week

Source: Pain and Central Nervous System Week (2005-04-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry